Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
41.04
+0.11 (0.27%)
Nov 20, 2024, 4:00 PM EST - Market closed
Astrana Health Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Astrana Health stock have an average target of 68.2, with a low estimate of 59 and a high estimate of 86. The average target predicts an increase of 66.18% from the current stock price of 41.04.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Astrana Health stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Maintains $67 → $86 | Buy | Maintains | $67 → $86 | +109.55% | Nov 13, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates $66 | Strong Buy | Initiates | $66 | +60.82% | Oct 14, 2024 |
| Keybanc | Keybanc | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 11, 2024 |
| BTIG | BTIG | Strong Buy Maintains $60 → $70 | Strong Buy | Maintains | $60 → $70 | +70.57% | Oct 3, 2024 |
| Baird | Baird | Buy Maintains $54 → $67 | Buy | Maintains | $54 → $67 | +63.26% | Aug 15, 2024 |
Financial Forecast
Revenue This Year
1.91B
from 1.39B
Increased by 37.96%
Revenue Next Year
2.38B
from 1.91B
Increased by 24.20%
EPS This Year
1.28
from 1.29
Decreased by -0.46%
EPS Next Year
1.61
from 1.28
Increased by 25.51%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.1B | 2.7B | 3.3B | ||
| Avg | 1.9B | 2.4B | 2.8B | ||
| Low | 1.7B | 2.1B | 2.4B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 51.4% | 42.7% | 38.0% | ||
| Avg | 38.0% | 24.2% | 18.5% | ||
| Low | 26.1% | 9.2% | 1.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.60 | 1.98 | 2.42 |
| Avg | 1.28 | 1.61 | 2.09 |
| Low | 1.06 | 1.16 | 1.51 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 23.7% | 54.5% | 49.9% |
| Avg | -0.5% | 25.5% | 29.6% |
| Low | -18.0% | -9.9% | -6.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.